Skip to main content

Table 3 Summary of antimicrobial susceptibility of Desulfovibrio species and actual antibiotic therapy

From: First case of a renal cyst infection caused by Desulfovibrio: a case report and literature review

 

Antimicrobial susceptibility (%)

Antimicrobial therapy (%)

MNZ

25 (78)

5 (23)

CLI

21 (66)

1 (4.5)

IPM

10 (31)

1 (4.5)

AMC

9 (28)

3 (14)

ETP

4 (13)

0

PEN

3 (9.4)

0

SAM

3 (9.4)

2 (9.1)

MEM

3 (9.4)

2 (9.1)

LVX

3 (9.4)

0

CIP

3 (9.4)

3 (14)

TZP

2 (6.3)

4 (18)

PAPM

1 (3.1)

0

AMP

1 (3.1)

2 (9.1)

CRO

1 (3.1)

3 (14)

  1. AMC amoxicillin-clavulanic acid, AMP ampicillin, CIP ciprofloxacin, CLI clindamycin, CRO ceftriaxone, ETP ertapenem, IPM imipenem, LVX levofloxacin, MEM meropenem, MNZ metronidazole, PAPM panipenem, PEN penicillin, SAM ampicillin-sulbactam, TZP piperacillin-tazobactam